SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-180394
Filing Date
2018-05-31
Accepted
2018-05-31 16:35:55
Documents
6
Effectiveness Date
2018-05-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A d595151ddefa14a.htm DEFA14A 40384
2 GRAPHIC g5951511.jpg GRAPHIC 898
3 GRAPHIC g5951512.jpg GRAPHIC 899
4 GRAPHIC g5951512a.jpg GRAPHIC 2788
5 GRAPHIC g5951513.jpg GRAPHIC 889
6 GRAPHIC g5951514.jpg GRAPHIC 904
  Complete submission text file 0001193125-18-180394.txt   51014
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 18872119
SIC: 2834 Pharmaceutical Preparations